Topical steroid withdrawal diagnostic criteria defined by researchers
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
Independent Journal Review31m
Check Out The Family Ties Of House Dem Championing Status Quo At NIH
A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...
Rolling Out3d
New drug outperforms therapy for severe food allergies
Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with ...
Mirage News2h
NIH Defines Topical Steroid Withdrawal Criteria
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
LAist on MSN21h
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
NIH reels with fear, uncertainty about future of scientific research
The Trump administration’s orders have created more turmoil and damage at the National Institutes of Health than was ...
News Medical on MSN11d
Omalizumab treats multi-food allergy better than oral immunotherapy
The high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
Tecovirimat is safe but ineffective as treatment for clade II mpox
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
CIDRAP2d
NIH cuts research grants on vaccine hesitancy—with mRNA vaccine studies the next target
Some of terminated grants focused on boosting uptake in minority populations, with the cuts covering a range of vaccines.
Sierra Sun Times1d
NIH Reports Tecovirimat is Safe But Ineffective as Treatment for Clade II Mpox
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.